Cullinan Therapeutics, Inc. (CGEM)
NASDAQ: CGEM · Real-Time Price · USD
20.52
-0.07 (-0.34%)
Aug 18, 2026, 1:13 PM EDT - Market open
Cullinan Therapeutics Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $30 | Buy | Reiterates | $30 | +46.20% | Aug 17, 2026 |
| UBS | UBS | Buy Maintains $24 → $27 | Buy | Maintains | $24 → $27 | +31.58% | Aug 17, 2026 |
| Morgan Stanley | Morgan Stanley | Buy Maintains $30 | Buy | Maintains | $30 | +46.20% | Aug 17, 2026 |
| Stifel Nicolaus | Stifel Nicolaus | Buy Maintains $28 | Buy | Maintains | $28 | +36.45% | Aug 13, 2026 |
| Clear Street | Clear Street | Buy Reiterates $46 → $47 | Buy | Reiterates | $46 → $47 | +129.04% | Aug 13, 2026 |
| William Blair | William Blair | Buy Reiterates n/a | Buy | Reiterates | n/a | n/a | Aug 13, 2026 |
| Citi | Citi | Buy Maintains $33 | Buy | Maintains | $33 | +60.82% | Aug 7, 2026 |
| JonesTrading | JonesTrading | Buy Maintains $36 | Buy | Maintains | $36 | +75.44% | Aug 6, 2026 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 3 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.